To validate this effect in vivo, immunofluorescence analysis was performed on a previously established orthotropic recurrent GBM model, which confirmed that recurrent tumors had increased IL-8 expression (Fig. 1e). The gene discussed is CXCL8; the disease is glioblastoma.